Theratechnologies PEG
Cos'è PEG di Theratechnologies?
PEG di Theratechnologies, Inc. è 740.91
Qual è la definizione di PEG?
Il rapporto prezzo / utili alla crescita (PEG) è il rapporto P / E di un titolo diviso per il tasso di crescita previsto dei suoi guadagni per un periodo di tempo di 5 anni.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG di aziende nel Health Care settore su TSX rispetto a Theratechnologies
Cosa fa Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Aziende con peg simili a Theratechnologies
- CenturyLink ha PEG di 419.23
- Tuniu Corp ha PEG di 453.00
- Western Digital ha PEG di 490.33
- Alexandria Real Estate Equities ha PEG di 537.70
- SFC AG ha PEG di 556.47
- Oxford Immunotec Global PLC ha PEG di 588.67
- Theratechnologies ha PEG di 740.91
- Hathway Cable and Datacom ha PEG di 770.00
- Upwork Inc ha PEG di 793.75
- Apartment Investment & Management Co ha PEG di 839.32
- Knight Therapeutics ha PEG di 861.00
- HealthCare Global Enterprises ha PEG di 1,059.90
- Shionogi & Co ha PEG di 24,611.80